ABL1 and acute lymphoblastic leukemia: Hence, a possible tumor suppressive mechanism of Ikaros is to activate the expression of a miRNA (hsa-miR-663a) that represses ABL1 expression to restrict cell growth, and mutation in IKZF1 in Ph+ B-ALL could relieve such oncogene repression by reduced tsmiR levels.